Well after you eat sizzle you tend to find yourself hungry again after not too long ...
Speaking of value, this KDUS release may flip-out a few value screens (if they are looking on the BB that is). A PE of .6 (only a one-time event of course) and standing at well under half cash on hand!
Friday March 30, 11:52 am Eastern Time
Press Release
SOURCE: Cadus Pharmaceutical Corporation
Cadus Reports Fourth Quarter and 2000 Results
NEW YORK, March 30 /PRNewswire/ -- Cadus
Pharmaceutical Corporation (OTC Bulletin Board: KDUS -
news) announced today financial results for the fourth
quarter and full year ended December 31, 2000.
Revenues for the fourth quarter of 2000 were $255,030,
compared to $0 for the same period in 1999. Net income
for the fourth quarter of 2000 was $447,969, compared
to a net loss of $1,227,818 for the same period in
1999. Basic and diluted net income per share for the
fourth quarter of 2000 was $0.04 compared to a basic
and diluted net loss per share for the fourth quarter
of 1999 of $0.09.
Revenues for the full year 2000 were $978,500,
compared to $6,027,544 for the same period in 1999.
Net income for the full year 2000 was $18,051,395,
compared to a net loss of $8,523,689 for the same
period in 1999. Basic and diluted net income per share
for the full year 2000 was $1.37, compared to a basic
and diluted net loss per share for the full year 1999
of $0.65. The net income for the full year 2000
includes the reversal of the reserve for litigation
damages of $18,841,489 (net of direct legal costs) as
a result of the reversal by the Court of Appeals, on
September 6, 2000, of the judgment that had been
obtained by SIBIA Neurosciences, Inc. in December
1998.
As of December 31, 2000, Cadus had 13,144,040 shares
outstanding.
I own a bunch and it mostly just sits there...
Peter |
